Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer
Open Access
- 15 July 2017
- journal article
- research article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 49 (3) , 656-668
Abstract
The biological function of long non-coding RNAs (lncRNAs) is only partially understood; therefore, in this study, we investigated the expression of the novel HOXA11 antisense (HOXA11as) lncRNA and its oncogenic role in serous ovarian cancer (SOC). HOXA11as expression was examined in 129 SOC tissue samples by real time reverse transcription polymerase chain reaction. Clinicopathological factors and patient survival were compared between the high (n=27) and low HOXA11as expression group (n=102). To investigate the role of HOXA11as in cell proliferation, invasion, and migration, HOXA11as expression in ovarian cancer cells was knocked down using RNA interference. HOXA11as expression in cancer tissue was 77-fold higher than that of noncancerous tissue (p < 0.05). Higher HOXA11as expression was significantly correlated with histological grade (p=0.017) and preoperative cancer antigen 125 (p=0.048). HOXA11as overexpression in SOC cells led to increased cell proliferation, invasion, and migration. Moreover, HOXA11as was associated with the expression of genes involved in cell invasion, migration, and epithelial-mesenchymal transition (EMT), including vascular endothelial growth factor, matrix metalloproteinase 9 (MMP-9), B-catenin, E-cadherin, Snail, Twist, and vimentin. Multivariate analysis revealed that HOXA11as was a prognostic factor of progressive disease and mortality (hazard ratio [HR], 1.730; p=0.043 and HR, 2.170; p=0.033, respectively). Progression-free and overall survival were significantly shorter in patients with high HOXA11as expression. These findings highlight the clinical significance of HOXA11as to predicting the prognosis of SOC patients and suggest its potential in promoting tumor aggressiveness via regulation of vascular endothelial growth factor (VEGF), MMP-9, and EMT-related mechanisms.Keywords
Funding Information
- National Research Foundation of Korea (2015R1A2A2A01008162, 2015R1C1-A2A01053516)
- Ministry of Education, Science and Technology
This publication has 29 references indexed in Scilit:
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancerBiochemical and Biophysical Research Communications, 2015
- Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinomaJournal of Experimental & Clinical Cancer Research, 2015
- LncRNA: A link between RNA and cancerBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2014
- HOX genes and their role in the development of human cancersJournal of Molecular Medicine, 2014
- The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer CellsCancer Research, 2013
- Long noncoding RNAs: functional surprises from the RNA worldGenes & Development, 2009
- Ovarian cancer: challenges of early detectionNature Clinical Practice Oncology, 2007
- Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomasOncogene, 2003
- Altered HOX and WNT7A expression in human lung cancerProceedings of the National Academy of Sciences, 2000